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Abstract
Since it was launched in 2006, PLOS ONE has published over fifty articles illustrating the many facets of the emerging field of
synthetic biology. This article reviews these publications by organizing them into broad categories focused on DNA
synthesis and assembly techniques, the development of libraries of biological parts, the use of synthetic biology in protein
engineering applications, and the engineering of gene regulatory networks and metabolic pathways. Finally, we review
articles that describe enabling technologies such as software and modeling, along with new instrumentation. In order to
increase the visibility of this body of work, the papers have been assembled into the PLOS ONE Synthetic Biology Collection
(www.ploscollections.org/synbio). Many of the innovative features of the PLOS ONE web site will help make this collection a
resource that will support a lively dialogue between readers and authors of PLOS ONE synthetic biology papers. The content
of the collection will be updated periodically by including relevant articles as they are published by the journal. Thus, we
hope that this collection will continue to meet the publishing needs of the synthetic biology community.
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Introduction
Synthetic biology is an emerging transdisciplinary field at the
intersection between many engineering and scientific disciplines
such as biology, chemical engineering, chemistry, electrical
engineering, or computer science. The scientific milestone that
inspired the development of synthetic biology is often regarded as
the description of two artificial gene networks in the same issue of
Nature in 2000 [1,2]. However, the year 2004 marks the
emergence of synthetic biology as a scientific community. This is
the year of the first synthetic biology conference, the first iGEM
competition –where students compete to build biological systems
(http://igem.org/) _ and the creation of the synthetic biology page
on Wikipedia. Two years later, the first issue of PLOS ONE
included two synthetic biology articles [3,4], marking the
beginning of a trend. Since then, PLOS ONE has published a
large number of articles covering all aspects of the field. Synthetic
biologists resolutely push the limits of their specialties in ways that
few established journals have been able to appreciate. Since the
result is often more ‘‘how to build something that works’’ rather
than primary biological insight, the papers can be hard to place in
classical journals. Many synthetic biology authors have benefited
from the innovative PLOS ONE editorial policy to publish
scientifically sound research, irrespective of its anticipated
significance.
The purpose of this article is to introduce the PLOS ONE
Synthetic Biology Collection (www.ploscollections.org/synbio/).
The collection highlights selected synthetic biology articles
published in PLOS ONE since 2006, putting them together in
one place for easy perusal. The website is intended to be a growing
resource that will be updated regularly.
We review the collection here by organizing it into some broad
categories: DNA synthesis and assembly, Biological parts, Protein
engineering, Networks and pathways, Synthetic life, Software and
modeling, and Instruments. The classification is our own; since
many synthetic biology papers cited in this review span more than
one category, it was sometimes difficult to assign them to one
category rather than another. Nonetheless, this structure should
aid in navigating the 50+ papers currently included in the
collection.
Summary of Papers Included in the Collection
DNA Synthesis and Assembly
Synthetic biology projects often begin with the assembly of
complicated, multi-component gene constructs. Therefore, both
DNA assembly and cloning technologies are critical enablers of
synthetic biology. Not surprisingly, many recent PLOS ONE
papers propose methods to improve the efficiency of the
fabrication step of synthetic biology projects. For example, Golden
Gate Cloning [5] is a one-step DNA assembly protocol that can
join at least nine distinct DNA fragments into one plasmid vector.
The technique employs type IIs restriction enzymes that cut DNA
at some distance from their cognate DNA-binding site, thus
allowing flexibility and uniqueness in the compatible sticky ends
that are generated. A related technique is GoldenBraid Assembly
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[6], that also uses type IIs restriction enzymes, but applies them
iteratively to standardized DNA parts (see the ‘Biological parts’
section below). This allows the indefinite growth of reusable gene
modules. Similarly, type IIs restriction enzymes have been used to
make a hierarchical modular cloning system aimed at making
eukaryotic multigene constructs [7].
‘One-pot’ assembly and cloning systems are being developed by
many groups, and the ideal systems use as few standardized
components as possible. Circular polymerase extension cloning
(CPEC) fits into this category, using a single polymerase to
assemble and clone multiple inserts with any vector, in a one-step
in vitro reaction [8]. Alternatively, successive hybridization
assembling (SHA) also employs a single reaction in vitro [9].
As well as cloning one desired multi-component construct,
many projects require degenerate cloning or mutagenesis to make
combinatorial libraries of gene variants. The OmniChange
technique, which simultaneously saturates five independent
codons, has therefore been developed to generate full-length gene
libraries with 5 degenerate NNK-codons while avoiding PCR-
amplification [10]. Large libraries of genetic sequences can be
derived from oligonucleotides synthetized in a microarray, and
later pooled in libraries from which more complex sequences can
be derived [11]. By combining linear DNA amplification and
PCR, DNA libraries with hundreds to thousands of members can
be synthesized.
PCR methods themselves can have certain limitations, such as
difficulties in amplifying GC-rich DNA targets. One study
optimized polymerase chain assembly (PCA) and ligase chain
reaction (LCR) methods for the construction of two GC-rich gene
fragments implicated in tumorigenesis, IGF2R and BRAF [12].
They found that LCR was superior and benefited from the
addition of DMSO and betaine.
The many synthesis and assembly methods presented in the
collection can be combined to streamline the fabrication steps of
synthetic biology projects, by producing collections of standardized
biological parts. Standard parts are themselves a distinctive feature
of synthetic biology, as reviewed below.
Biological Parts
The Registry of Standard Biological Parts (www.partsregistry.
org), based on the original vision of Tom Knight, is providing a
rich collection of components for synthetic biology projects.
Several articles in the PLOS ONE collection reflect the
importance of this resource. For example, a global analysis of
the Registry clone collection [13] helped identify certain
discrepancies between the sequences recorded in the database
and the physical sequences of some clones in the collection. These
results prompted a change in the quality control of the submissions
to the Registry that has greatly improved the overall quality of the
collection. Moreover, the analysis of parts usage patterns led to
organizational guidelines that may help design and manage these
new types of scientific resources. As most parts in the registry are
for prokaryotes, a eukaryotic collection of 52 parts was developed
and is available for distribution [14]. This includes multiple
cloning sites (MCS), common protein tags, protein reporters and
selection markers, amongst others. Furthermore, most of the parts
were designed in a format to allow fusions that maintain the
reading frame.
As well as standardized coding regions, synthetic biology
projects require well-characterized promoters to achieve desired
expression strengths. In one study, a single yeast promoter was
mutated to make a fine-graded output range promoter library
[15]. Transcription Activator-Like Orthogonal Repressors were
then developed synthetically to control expression of these
promoters in an orthogonal manner. Such orthogonality or
‘non-cross-reactivity’ is necessary for engineering larger synthetic
gene circuits that do not interfere with the physiology of the
biological chassis in which they operate. Mammalian synthetic
promoters have also been developed by analyzing motifs found in
highly active human promoters. Thus, by modulating the amount
of sequences rich in GC and CpGs, custom designed promoters
were obtained [16].
Finally, entirely de novo parts that are found nowhere in nature
have been engineered to slot into biological systems. Using E. coli
lacking conditionally essential genes, entirely new functional
proteins were obtained from scaffolds of randomized 4-helix
bundles, rescuing stalled growth [17]. Similarly, a synthetic ATP-
binding protein, evolved entirely from non-natural sequences, was
expressed in E. coli, altering the levels of intracellular ATP [18].
Protein engineering approaches are thus a potential source of
many new parts, as well as forming a branch of synthetic biology
in their own right.
Protein Engineering
Protein engineering can take many forms, from directed
evolution methods to protein design. The PLOS ONE Synthetic
Biology Collection includes a wide range of studies in this broad
field.
Phage display is one of the classic tools of protein engineering,
allowing combinatorial libraries of randomized proteins to be
selected from the surface of bacteriophages. Phage display was
used to generate a new class of binding proteins targeted to the
pointed-end of actin [19]. These proteins, called synthetic antigen
binders (sABs), were based on an antibody-like scaffold where
sequence diversity is introduced into the binding loops using a new
‘‘reduced genetic code’’ phage display library.
An example of targeted protein design was the design of a dual
reporter, Gemini [20]. Here, b-galactosidase (b-gal) a-fragment
was fused to GFP, resulting in increased b-gal activity and some
decrease in GFP sensitivity. GFP was also modified in a study
where the ten proline residues of enhanced green fluorescent
protein (EGFP) were replaced by (4R)- and (4S)-fluoroprolines
(FPro) [21]. In this way, protein folding and stability could be
tuned.
A promising advance in the field of engineering custom
sequence-specific DNA-binding proteins is the use of Transcrip-
tion Activator-Like (TAL) proteins. Modular TAL units specify A,
C, G or T and can be concatenated to make long designer DNA-
binding domains. Thus, Golden TAL Technology [22] has
adapted Golden Gate Cloning [5] for engineering new TAL
proteins. These were shown to function in human and plant cells
and to target activation of both exogenous and endogenous genes,
after fusion with a VP16 activation domain.
As well as single proteins, entire pathways can nowadays be
engineered. Computational redesign was used to create new
periplasmic binding proteins in plants, to act as biosensors in
combination with a histidine kinase signaling cascade [23]. This
resulted in transcription factor activation and ‘de-greening’ of
plants in response to small-molecule stimuli. As can be seen from
this example and the ones below, the move from single protein
engineering to network engineering is one of the main driving
forces in synthetic biology.
Networks and Pathways
One of the first, and now most-cited, synthetic biology papers in
PLOS ONE was the study on fitness-induced attractor selection
[3]. Here, a synthetic mutual inhibition gene network was built in
E. coli, with two states, green (GFP) and red (RFP), that were
PLOS ONE Synthetic Biology Collection
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mutually exclusive. By attaching a fitness pressure to one of the
states (i.e. a gene required for growth in the absence of glutamine),
the authors demonstrated that the cells switched stochastically into
the fittest state, restoring growth. In other words, by changing to a
glutamine-free medium, the red cells switched to green, even in the
absence of formal signaling machinery. This work has important
messages for potential new mechanisms in gene regulation, where
underlying fitness pressures can ultimately determine how much a
gene is expressed, simply according to need.
Other small bacterial networks have been built to include a
heritable sequential memory switch, using the fim and hin inversion
recombination systems [24], and an E. coli strain for use as a
‘chemical recording device’ [25]. In the latter, the authors created
a synthetic chemically sensitive genetic toggle switch to activate
appropriate fluorescent protein indicators (GFP, RFP) and along
with a cell division inhibitor (minC). Moving to yeast, one example
of network engineering was the reconstruction of a human p53-
Mdm2 negative feedback module in S. cerevisiae [26]. In this
example, many aspects of p53 regulation in mammals were
maintained, such as Mdm2-dependent targeting of p53 for
degradation, sumoylation at lysine 386 and further regulation of
this process by p14ARF. In mammalian systems, a synthetic
tetracycline regulator positive feedback loop was stably integrated
and yielded a bimodal expression response because such cells can
only be ‘‘OFF’’ or ‘‘ON’’ [27].
One unusual work in synthetic biology aimed to rewire and
control cell shape in yeast, by changing the inputs into the a-factor
pathway [28]. This pathway can give rise to multiple mating
projections, upon prolonged activation. The authors tested genetic
manipulations that ultimately gave rise to single or multiple
projections, in the absence of the natural input, a-factor.
A group of papers in the collection explore ‘synthetic ecology’,
where consortia of different cells interact to give patterns at a
population level. For example, by engineering two strains of E. coli,
one study was able to achieve synthetic biofilms with spatial self-
organization [29]. The consortia achieved defined layered
structures and had unexpected growth advantages. A second
paper describes a systems composed of two quorum-sensing signal
transduction circuits that allowed the authors to build a synthetic
ecosystem where the population dynamics could be tuned by
varying the environmental signals [30]. Third, quorum compo-
nents were also used in a study which generated robust but
unexpected oscillations in E. coli by building synthetic suicide
circuits [31]. In fact, the quorum components proved to be
unnecessary to achieve oscillations: there was a density-dependent
plasmid amplification that gave rise to population-level negative
feedback, ultimately resulting in the cycles. As in other areas of
synthetic biology, the process of building systems often leads to
surprises which can result in useful new engineering tools, or to a
better understanding of the underlying biological processes [32].
Pathway engineering for the production of useful chemical or
product synthesis is a major field within synthetic biology. For
example, an engineered yeast that efficiently secretes penicillin was
built by transplanting synthesis pathway components into a host
that is more suited for pharmaceutical production [33]. Artemi-
sinin derivatives are key components of malaria therapies and their
synthesis is a high-profile goal of synthetic biology because
extraction from slow-growing plants currently limits supply.
Consequently, one study achieved high-level production of an
artemisinin precursor in E. coli [34]. Another striking synthesis
paper demonstrates a synthetic enzymatic pathway consisting of
13 enzymes for high-yield hydrogen production from starch and
water [35]. Building such large systems is extremely challenging; as
a result, these articles have received a lot of attention.
Synthetic Life
Synthetic life is among the most controversial of synthetic
biology aims, and has received a lot of attention, even in the
mainstream press. Public concerns of possible biological threats
resulting from the misuse of these technologies prompted the
development of new biosecurity policies [36].
One branch of this field is the de novo chemical synthesis and
assembly of whole plasmids, viruses and genomes which are then
transplanted into host cells. The pX1.0 plasmid is an example of a
fully chemically-synthesized plasmid designed by calculating
consensus sequences from 8 plasmids [37], while removing genes
involved in antibiotic resistance and virulence. The plasmid not
only replicated in E. coli, but could also self-transfer by conjugation
into two other enterobacter species. A chemical synthesis approach
was also used to construct whole genomes of bacteriophage G4
(around 10 kilobases in length), resulting in infectious viruses that
could pass from one strain of E. coli to another [38].
One group has the ambitious long-term aim of building a
synthetic chloroplast, and has begun by transplanting photosyn-
thetic bacteria into eukaryotic cells to see whether they can achieve
synthetic symbiosis [39]. Remarkably, the authors showed that
some cyanobacteria were relatively harmless in zebrafish embryos,
compared to E. coli. Furthermore, by engineering invasins into the
cyanobacteria, they were able to invade and divide inside
mammalian macrophages. Synthetic biology is only limited by
our imagination, and one can speculate that entire free-living
synthetic lifeforms could find their place in the collection in the
not-too-distant future.
Software and Modeling
As the number of biological parts for synthetic biology increases,
databases and design methods must evolve. For example, to help
researchers search and retrieve biological parts, the Knowledge-
base of Standard Biological Parts (SBPkb) is a Semantic Web
resource for synthetic biology [40].
The collection also includes two articles presenting Computer
Assisted Design software tools. Eugene is a human readable
language to specify synthetic biological designs based on biological
parts. It also provides a very expressive constraint system to drive
the automatic creation of composite parts or devices from a
collection of individual parts [41]. Alternatively, the Proto
platform also provides a high-level biologically-oriented program-
ming language [42]. Specifications are compiled from regulatory
motifs, optimized, then converted into computational simulations
for numerical verification.
Ultimately the design tools are only as good as the underlying
mathematical models they rely on to make predictions of design
behaviors. The collection includes a number of articles applying
mathematical modeling approaches rooted in various engineering
specialties to the design of synthetic genetic constructs.
Modeling gene networks is at the interface of systems and
synthetic biology, and many PLOS ONE modeling papers aim to
guide bioengineering projects. A recent example of adapting
modeling for re-engineering properties into a system used a
standardized synthetic yeast network from the In-vivo Reverse-
engineering and Modeling Assessment (IRMA) [43]. Reverse
engineering itself was used in a study which ultimately provided
guidelines for chemotaxis pathway redesign [44]. Statecharts are
used to describe dynamical systems, but have not been applied to
gene networks. By doing so explicitly, one study was able to model
network motifs and combine them in a complicated interlocked
feed-forward loop network [45].
Two-component systems are common regulatory motifs in
bacteria, and comprise a kinase that senses environmental signals
PLOS ONE Synthetic Biology Collection
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together with a regulator that mediates the cell response. A recent
study asked the question, ‘‘what happens if you add a third
component that interacts with either of the other two?’’ [46].
Estimating the parameter space associated with a particular
function is very valuable for guiding synthetic engineering
approaches, as is determining whether a function is theoretically
possible at all. For example, using a geometric argument, it was
shown that, surprisingly, even monomer regulators can achieve
bistability. This demonstrates the possibility of switch-like behavior
in feedback autoloops without resorting to multimer regulators
[47].
By combining experiments and computation, one study was
able to derive design algorithms for altering synonymous codons in
proteins, resulting in drastic expression differences of the same
protein sequence [48]. For example, with DNA polymerase and
single chain antibodies, expression could be predictably tuned to
obtain concentrations ranging from undetectable to 30% of
cellular protein. Importantly, using partial least squares regression,
the authors noticed that favorable codons were predominantly
those read by tRNAs that are most highly charged during amino
acid starvation, not codons that are most abundant in highly
expressed E. coli proteins. This is an important discovery for
building genetic constructs that express appropriately inside the
target cells.
Computation is a key function of biological networks and
several studies in the collection present schemes to achieve this.
The first is implemented at the level of chemical reactions and
describes functions such as an inverter, an incrementer, a
decrementer, a copier, a comparator, a multiplier, an exponen-
tiator, a raise-to-a-power operation, and a logarithm in base two
[49]. A key simplification is that the scheme uses only two reaction
rates (‘‘fast’’ and ‘‘slow’’). A second study models a synthetic gene
network to perform frequency multiplication [50]. Both of these
studies assume deterministic relationships between input and
outputs. Recently, the deterministic assumption has been chal-
lenged by experimental and theoretical works analyzing the
importance of noise in the dynamics of gene networks [51]. This
trend is illustrated in the collection by an article demonstrating
that reliable timing of decision-making processes (choosing
between multistable states) can be accomplished for large enough
population sizes, as long as cells are globally coupled by chemical
means [52]. Modeling can often reveal subtle non-intuitive
designs, and, as a means of guiding synthetic biology, is likely to
become an even larger field in the future.
Instruments
Nowadays, new technology and machinery is an important
driving force for both primary biological discovery and for
synthetic biology. A neat example is provided by the use of inkjet
printer technology to provide low-cost high-resolution tools; a
bacterial piezoelectric inkjet printer was designed to print out
different strains of bacteria or chemicals in small droplets onto a
flat surface at high resolution [53]. Another group used an inkjet
for continuous dosing of diffusible regulators to a gel culture of
Figure 1. Historical distribution of synthetic biology articles published by PLOS ONE. This figure reports the number of articles in the
collection published between 2006 and 2011. It shows a rapid growth of synthetic biology that reflects the growth of the journal and the increased
familiarity of synthetic biologists with PLOS ONE.
doi:10.1371/journal.pone.0043231.g001
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E. coli, allowing 2D spatiotemporal regulation [54]. Precise
spatiotemporal control of cells can also be achieved with
microfluidics, and a recent report grew dividing yeast cells in a
remarkable planar array [55]. Transient pulses of gene expression
could be triggered by briefly inducing the GAL1 or MET3
promoters, resulting in coherent induction of cell division across
the cell cluster. Other novel culture systems presented in the
collection include the development of a 3-D cell culture system
using a designer peptide nanofiber scaffold that self-assembled [4].
The peptide could be linked to functional motifs for cell adhesion,
differentiation, and bone marrow homing for use with mouse adult
neural stem cells.
The Synthetic Biology Collection: A Dynamic
Community Resource
It is remarkable that the collection includes several articles
originating from engineers and computer scientists who tradition-
ally publish their work in conference proceedings rather than the
journals available to life-scientists. PLOS ONE’s indifference to
subject matter made it possible to publish an unprecedented body
of articles that reflects the multi-faceted nature of synthetic
biology. No less remarkable is the observation that PLOS ONE
published several articles originating from iGEM projects
[13,41,56].
Since 2006, the number of synthetic biology articles published
by the journal has been growing steadily (Figure 1). This evolution
is consistent with the social trends in synthetic biology that have
been mapped in an interesting bibliometric analysis included in
the collection [57]. This is an indication that the synthetic biology
community is becoming more aware of the services provided by
the journal. Looking forward, the collection will make it easier to
identify synthetic biology articles among the quickly growing
volume of articles published by the journal each day. The content
of the collection will be updated periodically as new synthetic
biology articles are published by the journal.
Although Journal Impact Factors are a widely-discredited form
of evaluating the quality of individual papers, all too often they are
still used. Thus, it is imperative to find a better alternative. One of
the most exciting features of the PLOS ONE web site is the
Metrics tab, displaying article-based metrics that can be used to
assess the impact of individual articles. These metrics naturally
include traditional indicators, such as the number of citations. The
two articles of the collection published in 2006 have been cited 70
and 84 times so far. Almost all the articles published in 2007 and
2008 have received more than 10 citations. The lag between the
publication of an article and its citation by others is well known.
Fortunately, the Metrics tab also includes more innovative
indicators that give the authors and readers alike a real-time
estimate of the ‘impact’ of an article. The number of times an
article is viewed is an important indicator. Since PLOS ONE is an
online journal, all readers view articles online in one way or
another. As a result, we hypothesized that the number of times an
article was viewed should be a good predictor of the number of
citations it will receive. Using data reported in Table S1, we
analyzed the relationship between views and citation numbers for
articles included in the collection that were published between
2006 and 2009. Figure 2 shows that there is a positive correlation
between the two metrics. That relationship does not hold when
including more recent articles because of a difference in timing
between viewing and citing activities. Articles typically receive a
substantial number of views in the first few months after
publication, but it takes a few years before they are cited. The
20 articles of the collection published in 2011 have recorded a lot
of views, but have not had the time to be cited in the literature yet.
A non-conventional form of citations displayed in the Metrics
tab is the number of times an article is bookmarked in social
media. We have reported the Mendeley (www.mendeley.com)
data in Table S1. Figure 2 shows that there is a positive
relationship between the number of views and the number of times
articles are bookmarked in this network, at least for the most
recent articles of the collection. Older articles are under-
represented in Mendeley because this network was not available
at the time these articles were published. It will be interesting to
see if citations of the collection articles in social media will be a
better predictor of citations in the scientific literature than the
number of views.
One overarching theme of synthetic biology is standardization
[58,59], which can only be achieved through concerted efforts by
members of the community. The field has therefore been deeply
influenced by the development of resources such as the Registry of
Standard Biological Parts (www.partsregistry.org ). More recently,
the development of SBOL, the Open Language for Synthetic
Biology (www.sbolstandard.org) illustrates the need to agree on
data formats suitable to the development of software tool chains
necessary to support experimental efforts. Each article published in
PLOS ONE can be the start of a lively conversation. The journal
web site provides authors and readers alike with a detailed vision
of community connections. The ‘‘Share this article’’ feature allows
readers to quickly send an article they find interesting to their
networks. The comments tab of the articles provides the
community with means to engage in a dialogue focused on
specific articles [5,35,48,55]. This feature can also be used by
authors to provide updated information about the work presented
in the article [13].
When working at its best, science should be an active
conversation that keeps refining ideas. We believe that PLOS
ONE provides the ideal venue to achieve this, and we hope that
the collection will inspire further progress in synthetic biology.
Ultimately, we hope that having a clear repository in PLOS ONE
should further increase its attractiveness as a home for publishing
synthetic biology.
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Figure 2. Relationships between article-level metrics. For articles published between 2006 and 2009, there is a positive correlation between
the number of times an article is cited in the scientific literature and the number of times it is viewed (A). For articles published between 2010 and
2012, there is a positive relationship between the number of views and the number of citations in the Mendeley social network (B). Metrics, such as
number of views and citations in social media, give readers and authors an estimate of the scientific impact of individual articles well before they
receive citations in scientific literature.
doi:10.1371/journal.pone.0043231.g002
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